Correlation Between Tekla Healthcare and Morgan Stanley
Can any of the company-specific risk be diversified away by investing in both Tekla Healthcare and Morgan Stanley at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tekla Healthcare and Morgan Stanley into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tekla Healthcare Investors and Morgan Stanley India, you can compare the effects of market volatilities on Tekla Healthcare and Morgan Stanley and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tekla Healthcare with a short position of Morgan Stanley. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tekla Healthcare and Morgan Stanley.
Diversification Opportunities for Tekla Healthcare and Morgan Stanley
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Tekla and Morgan is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Tekla Healthcare Investors and Morgan Stanley India in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Morgan Stanley India and Tekla Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tekla Healthcare Investors are associated (or correlated) with Morgan Stanley. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Morgan Stanley India has no effect on the direction of Tekla Healthcare i.e., Tekla Healthcare and Morgan Stanley go up and down completely randomly.
Pair Corralation between Tekla Healthcare and Morgan Stanley
Considering the 90-day investment horizon Tekla Healthcare Investors is expected to under-perform the Morgan Stanley. In addition to that, Tekla Healthcare is 1.54 times more volatile than Morgan Stanley India. It trades about -0.09 of its total potential returns per unit of risk. Morgan Stanley India is currently generating about 0.1 per unit of volatility. If you would invest 2,777 in Morgan Stanley India on September 4, 2024 and sell it today you would earn a total of 51.00 from holding Morgan Stanley India or generate 1.84% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tekla Healthcare Investors vs. Morgan Stanley India
Performance |
| Timeline |
| Tekla Healthcare Inv |
| Morgan Stanley India |
Tekla Healthcare and Morgan Stanley Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tekla Healthcare and Morgan Stanley
The main advantage of trading using opposite Tekla Healthcare and Morgan Stanley positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tekla Healthcare position performs unexpectedly, Morgan Stanley can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Morgan Stanley will offset losses from the drop in Morgan Stanley's long position.| Tekla Healthcare vs. Tekla Healthcare Opportunities | Tekla Healthcare vs. Eaton Vance Tax | Tekla Healthcare vs. Tekla World Healthcare | Tekla Healthcare vs. Cohen Steers Limited |
| Morgan Stanley vs. Aberdeen Income Credit | Morgan Stanley vs. BlackRock Utility Infrastructure | Morgan Stanley vs. Aberdeen Australia Ef | Morgan Stanley vs. Pgim High Yield |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |